Voya Financial Advisors, Inc. Biogen Inc. Transaction History

Voya Financial Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $349,391 - $559,443	-1,349 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $13,848 - $16,223	57 Added 4.41%	1,349 $372,000
Q4 2020 Mar 05, 2021	SELL	$236.26 - $355.63 $4,016 - $6,045	-17 Reduced 1.3%	1,292 $315,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $7,943 - $9,171	-30 Reduced 2.24%	1,309 $370,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $7,242 - $9,591	28 Added 2.14%	1,339 $349,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $27,960 - $35,468	-104 Reduced 7.35%	1,311 $414,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $7,482 - $10,338	34 Added 2.46%	1,415 $419,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $58,273 - $65,359	-268 Reduced 16.25%	1,381 $318,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $60,743 - $66,956	-277 Reduced 14.38%	1,649 $395,000
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $44,208 - $69,147	204 Added 11.85%	1,926 $448,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $78,815 - $99,828	283 Added 19.67%	1,722 $505,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $102,728 - $134,340	350 Added 32.14%	1,439 $512,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $280,439 - $334,224	1,089 New	1,089 $314,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.